93 related articles for article (PubMed ID: 11338682)
1. [Clinical effects of combination therapy with cefozopran and amikacin for infections in patients with hematological disorders].
Fukuda M; Endo K; Takinami S; Kawai N; Tominaga K; Maesaki S; Bessho M; Yamazaki T
Jpn J Antibiot; 2001 Feb; 54(2):88-94. PubMed ID: 11338682
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders].
Fukuda M; Kobayashi Y; Endo K; Kawai N; Tominaga K; Bessho M; Hirashima K
Jpn J Antibiot; 1998 Apr; 51(4):298-304. PubMed ID: 9644603
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
Urabe A; Fujita A; Aoki K; Koike M; Kitamura K; Ohbayashi Y; Oshimi K; Wakabayashi Y; Kuraishi Y; Kurihara I; Togawa A; Hoshino S; Ozawa K; Hotta T; Higashihara M; Nagoshi H; Hirai H; Omine M; Asano S; Nishimura M; Suzuki K; Bessho M; Mizoguchi H; Furusawa S; Nonaka Y; Takaku F
Jpn J Antibiot; 2000 Feb; 53(2):61-74. PubMed ID: 10786314
[TBL] [Abstract][Full Text] [Related]
4. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of cefozopran for infections associated with hematological malignancies].
Sasai Y; Iwai T; Tamura A; Nakazawa N; Ueda Y; Kaneko H; Horiike S; Yokota S; Taniwaki M; Kashima K; Misawa S; Tsuda S; Ohgawara Y
Jpn J Antibiot; 1998 Aug; 51(8):501-8. PubMed ID: 9836122
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of neutropenic fever associated with hematological disorders].
Fukuda M; Endo K; Ito K; Kawai N; Tominaga K; Bessho M; Hirasima K
Kansenshogaku Zasshi; 2001 Mar; 75(3):186-92. PubMed ID: 11321778
[TBL] [Abstract][Full Text] [Related]
7. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
Takashima T; Tsuda S; Misawa S; Horiike S; Kuzuyama Y; Hirakawa K; Nakai H; Seriu T; Tanaka S; Nishida K
Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
[TBL] [Abstract][Full Text] [Related]
8. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
Matsushima T; Tamura K; Okamoto K; Kawada E; Murayama K; Maehara T; Sadakata H; Tamura J; Sawamura M; Morita K
Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
Yamane T; Tanaka K; Hasuike T; Hirai M; Misu K; Ota K; Ohira H; Nakao Y; Yasui Y; Inoue T
Jpn J Antibiot; 1992 Aug; 45(8):1050-9. PubMed ID: 1433894
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
Tanaka S; Tsuda S; Nakagawa H; Nishigaki H; Okuda T; Taniwaki M; Misawa S; Takino T; Abe T
Jpn J Antibiot; 1989 Dec; 42(12):2548-54. PubMed ID: 2614912
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of cefpirome sulfate for severe infections in patients with hematological disorders. Hanshin Study Group of Hematopoietic Disorders and Infections].
Hamazaki H; Hasegawa H; Horiuchi A; Teshima H; Hiraoka A; Masaoka T; Nasu K; Uchino H; Tatsumi N; Inoue N; Kageyama T; Kawagoe H; Tukaguchi M; Hukuhara S; Takahashi T; Takatsuka H; Kanamaru A; Kakishita E; Nagai K; Hara H; Kanayama Y; Sugiyama H; Kitani T
Jpn J Antibiot; 1997 Jan; 50(1):12-21. PubMed ID: 9059910
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of cefozopran as treatment for febrile neutropenia].
Saito T; Hara M; Shinagawa K; Nawa Y; Nakase K; Takeuchi M; Miyata A; Fukuda S; Sunami K; Imajoh K; Yano T; Kojima K; Teshima T; Fujii N; Ishimaru F; Ikeda K; Harada M; Tanimoto M
Gan To Kagaku Ryoho; 2004 Jan; 31(1):61-5. PubMed ID: 14750323
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran].
Fujii R; Abe T; Tajima T; Terashima I; Meguro H; Nakazawa S; Sato H; Niinou K; Sunakawa K; Yokota T
Jpn J Antibiot; 1994 Jan; 47(1):102-23. PubMed ID: 8114268
[TBL] [Abstract][Full Text] [Related]
14. [Clinical effects of a combination treatment with fosfomycin and clavulanic acid/ticarcillin for infections in patients complicated with hematological disorders].
Hirakawa K; Tsuda S; Misawa S; Ueda Y; Kaneko H; Nakao M; Ariyama Y; Nakai H; Seriu T; Takashima T
Jpn J Antibiot; 1994 May; 47(5):521-9. PubMed ID: 8051794
[TBL] [Abstract][Full Text] [Related]
15. [Clinical effects of combination therapy with cefozopran and tobramycin for severe infections in patients with hematologic diseases].
Toyama K; Yaguchi M; Uchida Y; Suzuki K; Sawanobori M; Ikeda Y; Matsuoka S; Wakasugi K; Furuya T; Oshimi K; Kawamata N; Kikuchi M; Murakami H; Tsuruoka N; Tomoyasu S; Kawaguchi M; Hirosawa S; Yamamoto K; Shirota T; Harada Y; Dan K; Yamada T; Kawano K; Onozawa Y; Takeuchi J
Jpn J Antibiot; 1999 Feb; 52(2):153-61. PubMed ID: 10221180
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study on a concomitant therapy with fluconazole and human recombinant granulocyte colony stimulating factor in the treatment of systemic fungal infections with hematological disorders].
Kitamura K; Miyagawa K; Urabe A; Sato H; Obayashi Y; Aoki I; Takaku F; Togawa A; Shindou E; Wakabayashi Y; Ohshima T; Horikoshi A; Nomura T; Ohki I; Suzuki K; Kamakura M; Oguchi A; Toyama K; Yaguchi M; Aoki N; Kato A; Mizoguchi H; Masuda M; Irie S; Fujioka S
Jpn J Antibiot; 1996 Dec; 49(12):1062-72. PubMed ID: 9032593
[TBL] [Abstract][Full Text] [Related]
17. Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients.
Ohyashiki K
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S56-8. PubMed ID: 15250023
[TBL] [Abstract][Full Text] [Related]
18. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
[TBL] [Abstract][Full Text] [Related]
19. [Clinical effects of a combination treatment with cefodizime and minocycline for infections in patients complicated with hematological disorders].
Hirakawa K; Tsuda S; Misawa S; Kuzuyama Y; Nakai H; Seriu T; Takashima T; Tanaka S; Nishigaki H; Yokota S
Jpn J Antibiot; 1993 Aug; 46(8):686-96. PubMed ID: 8230736
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of amikacin by intravenous drip infusion for infections in the field of internal medicine].
Ito A; Maruta I; Ogawa K; Asada H; Matsuzaki M
Jpn J Antibiot; 1985 Aug; 38(8):2108-18. PubMed ID: 4079002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
